Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Class D β-lactamases (oxacillinases) are serine hydrolases that confer bacterial antibiotic resistance by breaking down β-lactam antibiotics, including penicillins, cephalosporins, and carbapenems.[1][3] These enzymes belong to a distinct subset of the β-lactamase superfamily and operate through a sophisticated serine-dependent catalytic mechanism involving a carbamylated lysine residue that facilitates hydrolysis of the characteristic β-lactam ring found in these antibiotics.[1][4] Originally recognized for their ability to hydrolyze oxacillin and related compounds, Class D β-lactamases are now a major clinical concern due to the emergence of OXA carbapenemases, which can degrade last-resort carbapenem antibiotics in Acinetobacter baumannii and other gram-negative pathogens.[3][4] These enzymes represent a significant therapeutic challenge because their rapid hydrolysis of antibiotic substrates, combined with secondary resistance mechanisms and the ability to spread via plasmids across bacterial species, makes infections difficult to treat.[2][3] Efforts to develop new antibiotics and β-lactamase inhibitors target Class D enzymes as a key strategy to combat rising antibiotic resistance.
The enzyme operates through a serine-dependent catalytic mechanism involving four key steps: 1. Nucleophilic activation — Carbamylated lysine (Kcx70) deprotonates serine 67, enabling it to attack the carbonyl group of the β-lactam ring and form a tetrahedral intermediate 2. Intermediate collapse — The tetrahedral intermediate collapses, cleaving the C-N bond through a proton relay cascade 3. Water-mediated hydrolysis — The carbamylated lysine deprotonates water, which attacks the covalently attached intermediate in a nucleophilic addition 4. Enzyme regeneration — The tetrahedral intermediate collapses, eliminating serine 67 and releasing the hydrolyzed product while regenerating the catalytically active enzyme This mechanism results in rapid hydrolysis of the acyl-enzyme intermediate, preventing the enzyme from becoming inhibited by β-lactams in the same way as penicillin-binding proteins.[1]
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Class D β-lactamase (also known as oxacillinase) (OXA).